Black Rose Industries shareholders have approved the re-appointment of Ambarish Daga and Shruti Jatia as Whole-Time Directors, marking a key governance update for the chemical manufacturer. The approvals came via a postal ballot process that concluded on August 5, 2026, with both special resolutions passing with overwhelming support from public non-institutional investors. This outcome ensures continuity in the company’s executive leadership, as both directors retain their roles critical to operational strategy and management.

The voting results were submitted to BSE Limited on August 6, 2026, pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The postal ballot notice was originally issued on May 13, 2026. M/s. Shiv Hari Jalan & Co., Practicing Company Secretaries, served as the scrutinizer for the e-voting process, which was facilitated by National Securities Depository Limited (NSDL). The scrutinizer’s report, dated August 5, 2026, confirmed that the voting procedure adhered to Section 110 of the Companies Act, 2013, and Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014.

Voting Results Overview

The record date for the postal ballot was July 3, 2026. On this date, there were 51,177 shareholders registered. The total number of shares held by all categories combined was 51,000,000. Voting was conducted exclusively through remote e-voting; no physical polling or postal ballot submissions were recorded. Promoter and promoter group shareholders, who hold 38,249,850 shares, did not participate in the voting for either resolution. Similarly, public institutional shareholders, holding 90,071 shares, cast no votes.

All valid votes originated from public non-institutional shareholders, who hold 12,660,079 shares. The engagement level from this category was consistent across both resolutions, with approximately 0.89% to 0.90% of outstanding shares polled. The high approval rates indicate strong confidence among retail and small institutional investors in the continued tenure of the designated directors.

Resolution Details

Ambarish Daga (DIN: 07125212) received 110,257 votes in favour out of 112,362 votes polled, representing 98.126% support. Only 2,105 votes were cast against his re-appointment. Shruti Jatia (DIN: 00227127) saw slightly higher participation, with 114,028 votes polled. She secured 112,103 affirmative votes, equating to 98.311% support, with 1,925 votes against.

Procedural Compliance and Scrutiny

The e-voting module opened at 9:00 a.m. IST on July 7, 2026, and closed at 5:00 p.m. IST on August 5, 2026. Upon closure, NSDL blocked the e-voting module. The votes were unblocked and downloaded on August 5, 2026, at 5:11 p.m., witnessed by independent witnesses Jata Shankar Vishwakarma and Swapnil Gamare, neither of whom are employed by Black Rose Industries or NSDL.

Shiv Hari Jalan, Proprietor of Shiv Hari Jalan & Co., confirmed that the management fulfilled its responsibilities under the Companies Act, 2013, including compliance with General Circular Nos. 17/2020, 14/2020, 03/2025, 09/2024, and 09/2023 issued by the Ministry of Corporate Affairs. The Postal Ballot Notice and explanatory statement under Section 102 of the Act were sent electronically to members with registered email addresses. All electronic data and records have been handed over to the Company Secretary for safekeeping.

Black Rose Industries delivered a robust financial performance in the first quarter of FY27, with standalone net profit after tax (PAT) surging 146% year-on-year to ₹10.4 crore. The Mumbai-based chemical manufacturer and distributor posted total revenue of ₹90.1 crore for the quarter ended June 30, 2026, up 48% from ₹60.9 crore in Q1FY26. The earnings acceleration was primarily driven by a sharp expansion in its distribution business, which saw revenue more than double, alongside improved margins across key product categories. The Board of Directors declared an interim dividend of ₹2 per equity share, reflecting confidence in the company’s cash flow generation and operational leverage.

The Board meeting held on July 31, 2026, approved the unaudited financial results pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory Auditors M M Nissim & Co LLP issued an unmodified limited review report. The record date for dividend entitlement is fixed for August 6, 2026. Additionally, the Board reaffirmed the voluntary winding up of its wholly-owned Japanese subsidiary, B.R. Chemicals Co. Limited, which contributed nil turnover in the last financial year.

Segment-wise Performance

The distribution division emerged as the primary growth engine, contributing ₹62.7 crore to revenue, a significant jump from ₹32.8 crore in the corresponding quarter last year. This segment’s EBITDA expanded sharply to ₹10.5 crore from ₹1.8 crore, benefiting from higher sales realizations following market price rises post-West Asia conflict and healthy export volumes to the US oil & gas sector. Conversely, the manufacturing division reported resilient but flat revenue of ₹26.4 crore, similar to Q1FY26 levels, as sequential volumes moderated due to customer inventory adjustments. However, manufacturing EBITDA improved to ₹7.3 crore from ₹6.1 crore, supported by favorable pricing trends in solid acrylamide and better spreads in liquid acrylamide despite lower raw material costs.

Key Financial Indicators

The company’s financial health remained strong, with the debt-to-equity ratio improving to 0.001 from 0.006 in Q1FY26. The quarterly interest coverage ratio nearly doubled to 59.6 times from 29.2 times, indicating robust debt servicing capacity. Return on equity (ROE) climbed significantly to 23.2% from 11.0% year-ago. EBITDA margin expanded to 17.33% from 11.5%, while net profit margin rose to 11.68% from 7.1%. Inventory turnover improved to 1.16 times from 0.68 times, signaling efficient stock management.

What the Numbers Show

The disproportionate rise in profitability relative to revenue growth highlights a structural shift in Black Rose Industries’ earnings mix. With distribution revenue now constituting 2.38 times that of manufacturing (up from 1.22 times), the company is increasingly leveraging its stock-and-sale model to capture margin expansion during periods of price volatility. While sequential revenue declined by 14% from the elevated base of Q4FY26, the ability to maintain EBITDA growth of 12% demonstrates effective cost control and pricing power. The near-zero debt position and high interest coverage ratio provide ample financial flexibility for upcoming capacity expansions, including the piloting of Polyacrylamide (PAM) solid projects and potential collaboration with Koei Chemical Company, Ltd. for specialty amines.